Vanta Bioscience Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vanta Bioscience Ltd. on BSE

Load latest

Vanta Bioscience Ltd.

30 Jul 2018

24.32

1.97%

Company Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

We are happy to announce that Vanta Bioscience Limited (Scrip Code 540729), which is in the business of pre-clinical services, announced its foray into Clinical Research through a 100% subsidiary. The clinical research business will begin contributing to the top-line in the last quarter of the current financial year. The Company is projecting to add a revenue of Rs.250 crores in the fifth year through clinical research services. In this regards, please find enclosed a Press Release.

pdf

Vanta Bioscience Ltd.

27 Jul 2018

24.32

1.97%

Corp. Note

Outcome of Board Meeting

BSE India

Outcome of Board Meeting on July 27, 2018

pdf

Vanta Bioscience Ltd.

24 Jul 2018

24.32

1.97%

Company Update

Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

The Company has entered into exclusive service agreement with Hongkong Thinkway Trading Limited for China, APAC & LATAM. Press Release is enclosed

pdf

Vanta Bioscience Ltd.

20 Jul 2018

24.32

1.97%

Board Meeting

Board Meeting-Outcome of Board Meeting

BSE India

Outcome of Board Meeting held on July 20, 2018

pdf

Vanta Bioscience Ltd.

16 Jul 2018

24.32

1.97%

Company Update

Statement Of Investor Complaints For The Quarter Ended June 2018

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer

Vanta Bioscience Ltd.

04 Jul 2018

24.32

1.97%

Corp. Note

Board Meeting-Appointment of Chief Financial Officer (CFO)

BSE India

The Board of Directors in their meeting held today i.e., July 04, 2018 have appointed Mr. A Kiran Kumar as the Chief Financial Officer (CFO) of the Company with immediate effect.

pdf

Vanta Bioscience Ltd.

21 May 2018, 03:50PM

24.32

1.97%

Company Update

Statement Of No Deviation Or Variation In Use Of Proceeds From Public Issue As At March …

BSE India

Statement of no deviation or variation in use of proceeds from Public Issue as at March 31, 2018

pdf

Vanta Bioscience Ltd.

21 May 2018, 03:48PM

24.32

1.97%

AGM

Outcome of Board Meeting (AGM on August 21, 2018)

BSE India

Vanta Bioscience Ltd has informed BSE about Outcome of Board Meeting held on May 21, 2018.

pdf

Vanta Bioscience Ltd.

21 May 2018, 03:38PM

24.32

1.97%

Result

Financial Results For The Half Year And Year Ended 31.03.2018

BSE India

Financial results for the half year and year ended 31.03.2018

pdf

Vanta Bioscience Ltd.

10 May 2018

24.32

1.97%

Board Meeting

Board Meeting On May 21, 2018

BSE India

Board Meeting is scheduled to be held on May 21, 2018 to consider and approve the Audited Financial Statements of the Company for the half year and year ended March 31, 2018 and other matters.

pdf

Is Vanta Bioscience Ltd. worth buying?

4 Votes:

Buy 75.0%

Sell 25.0%